ClinicalTrialsFinder

Scientific Research Institute of Cardiology and Internal Disease of the Ministry of Health of the Republic of Kazakhstan

Almaty, Kazakhstan

1 recruiting

Showing 1–1 of 1 trials

Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled215 locationsNCT06226883